262 related articles for article (PubMed ID: 31996161)
21. Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
Bekolo CE; Soumah MM; Tiemtore OW; Diallo A; Yuma JD; Di Stefano L; Metcalf C; Cisse M
BMC Cancer; 2017 Dec; 17(1):806. PubMed ID: 29197357
[TBL] [Abstract][Full Text] [Related]
22. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
25. Beyond T Staging in the "Treat-All" Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa.
Freeman EE; Semeere A; McMahon DE; Byakwaga H; Laker-Oketta M; Regan S; Wenger M; Kasozi C; Ssemakadde M; Bwana M; Kanyesigye M; Kadama-Makanga P; Rotich E; Kisuya J; Wools-Kaloustian K; Bassett IV; Busakhala N; Martin J
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1119-1127. PubMed ID: 33871409
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia.
Mtonga W; Mujajati A; Munkombwe D; Kalungia A; Muungo LT; West J; Wood C; Ngalamika O
Curr HIV Res; 2018; 16(3):231-236. PubMed ID: 29992888
[TBL] [Abstract][Full Text] [Related]
27. Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
Semeere A; Freeman E; Wenger M; Glidden D; Bwana M; Kanyesigye M; Asirwa FC; Rotich E; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Adebamowo C; Jaquet A; Dabis F; Phiri S; Bohlius J; Egger M; Yiannoutsos CT; Wools-Kaloustian K; Martin J
BMC Cancer; 2017 Sep; 17(1):611. PubMed ID: 28865422
[TBL] [Abstract][Full Text] [Related]
28. Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.
Macken M; Dale H; Moyo D; Chakmata E; Depani S; Israels T; Niyrenda D; Bailey S; Chagaluka G; Molyneux EM
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988435
[TBL] [Abstract][Full Text] [Related]
29. Kaposi sarcoma in South African children.
Stefan DC; Stones DK; Wainwright L; Newton R
Pediatr Blood Cancer; 2011 Mar; 56(3):392-6. PubMed ID: 21225916
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
31. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
32. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
[TBL] [Abstract][Full Text] [Related]
33. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi's sarcoma in western Kenya.
Strother RM; Gregory KM; Pastakia SD; Were P; Tenge C; Busakhala N; Jakait B; Schellhase EM; Rosmarin AG; Loehrer PJ
Oncology; 2010; 78(1):5-11. PubMed ID: 20215784
[TBL] [Abstract][Full Text] [Related]
35. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma.
Paparizos VA; Kyriakis KP; Mileounis KA; Pfandl-Polydorou D; Stavrianeas NG; Vareltzidis AG; Stratigos JD
J Chemother; 1996 Oct; 8(5):403-6. PubMed ID: 8957723
[TBL] [Abstract][Full Text] [Related]
36. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
[TBL] [Abstract][Full Text] [Related]
38. Low-dose multidrug chemotherapy plus Pneumocystis carinii pneumonia prophylaxis for HIV-related Kaposi's sarcoma.
Shields PG; Dawkins F; Holmlund J; Cohen P; Schulof RS
J Acquir Immune Defic Syndr (1988); 1990; 3(7):695-700. PubMed ID: 1693677
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: bleomycin/vincristine compared to vincristine monotherapy.
Mwafongo AA; Rosenberg NE; Ng'ambi W; Werner AB; Garneau WM; Gumulira J; Phiri S; Hosseinipour MC
PLoS One; 2014; 9(3):e91020. PubMed ID: 24632813
[TBL] [Abstract][Full Text] [Related]
40. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).
Stein ME; Lachter J; Spencer D; Margolius L; Bezwoda WR
Acta Oncol; 1996; 35(2):193-9. PubMed ID: 8639315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]